Research and Markets: US Coagulation Testing Market 2014-2019: Sales Forecasts, Supplier Shares, Competitive Strategies

Australian Business
Print
image image

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/zvn35g/us_coagulation) has announced the addition of the "US Coagulation Testing Market 2014: Sales Forecasts, Supplier Shares, Competitive Strategies" report to their offering.

The report explores business and technological trends in the US coagulation testing market provides estimates of the test volume, as well as sales and market shares of leading competitors compares features of major analyzers profiles leading market players and identifies specific product and business opportunities facing instrument and consumable suppliers during the next five years.

Coagulation Tests

Activated Clotting Time (ACT) (1), Activated Protein C Resistance, Activated PTT (APTT), Alpha 2-Antiplasmin, Antithrombin III, Bleeding Time, D-Dimer, Factor II, Factor V, Factor V Leiden, Factor VII, Factor VIII, Factor IX, Factor Ixa, Factor X (Stuart Factor), Factor Xa, Factor XI, Factor XII, Factor XIII, Fibrin Degradation Products, Fibrinogen, Fletcher Factor/Pre-Kallikrein Factor Activation, Heparin/Anti-Factor Xa, Heparin-Induced Thrombocytopenia, Plasmin, Plasminogen, Plasminogen Activator Inhib., Platelet Function/Aggregation, Protein C, Protein S, Prothrombin Mutation, Prothrombin Time (PT), Reptilase Time, Thrombin Time, Von Willebrand's Factor Fav/Ag, and others.

Sales and Market Share Analysis

Competitive Assessments

Market Segmentation Analysis

Current and Emerging Products

Technology Review

Strategic Recommendations

For more information visit http://www.researchandmarkets.com/research/zvn35g/us_coagulation